Previous 10 | Next 10 |
2023-11-28 12:34:54 ET More on iCAD iCAD, Inc. (ICAD) Q3 2023 Earnings Call Transcript iCAD Q3 2023 Earnings Preview iCAD to sell brachytherapy business line Xoft to Elekta for $5.5M Seeking Alpha’s Quant Rating on iCAD Historical earnings data...
2023-11-28 10:00:04 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom For further details see: Seelos Therape...
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and support clinicians in delivering more personalized breast care, including cancer detection, density assessment, and recommendations...
New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a woman’s one to two-year risk for breast cancer iCAD unveils new solution that assesses calcium deposits in the ...
Offering radiology the most complete breast health solution, including breast density assessment, breast cancer detection, and thorough risk evaluation, including lifetime, genetic, and short-term 1- or 2-year AI-risk Partnership to expand access to ProFound Breast Health Suite and Ca...
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today announced that Dana Brown, President and Chief Executive Officer and Eri...
2023-11-13 22:50:23 ET Vodacom Group Limited (VODAF) Q3 2023 Earnings Conference Call November 14, 2023 16:30 ET Company Participants Leonor Faber - Assistant to Chief Executive Officer Dana Brown - President & Chief Executive Officer Eric Lonnqvist - Chief F...
2023-11-13 16:05:55 ET More on iCAD iCAD Q3 2023 Earnings Preview iCAD to sell brachytherapy business line Xoft to Elekta for $5.5M Seeking Alpha’s Quant Rating on iCAD Historical earnings data for iCAD Financial information for iCAD Fo...
NASHUA, N.H., Nov. 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three and nine mont...
INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...
News, Short Squeeze, Breakout and More Instantly...
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today reported its financial and operating results for the three months ended M...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
NASHUA, N.H., May 08, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:ICAD), a global leader in clinically proven AI-powered cancer detection soluti...